Condition

Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials and research

• 6Clinical trials
• 2Countries

Newest Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials

All recruiting trials (6)

• QLS31905 plus CAPOX vs sintilimab plus CAPOX as first-line treatment for gastric/GEJ cancer

  This phase 3 trial tests whether QLS31905 with CAPOX works as well as or better than sintilimab with CAPOX for first-line treatment in CLDN18.2-positive, PD-L1 CPS < 5, HER2-negative unresectable or metastatic gastric/GEJ cancer.

  Recruiting Phase 3 Qilu Pharmaceutical Co., Ltd. · Beijing · NCT07716449

• Perioperative chemo with low-dose radiotherapy and tislelizumab for locally advanced gastric/GEJ cancer

  This trial tests whether adding low-dose radiotherapy and tislelizumab to perioperative chemotherapy helps people with resectable locally advanced gastric or gastroesophageal junction cancer.

  Recruiting Phase 2 Jiangsu Cancer Institute & Hospital · Nanjing, Jiangsu · NCT07408609

• HLX43 (an anti-PD-L1 antibody–drug conjugate) for advanced stomach or gastroesophageal junction adenocarcinoma

  This will try different IV doses of HLX43 to see if it helps adults with advanced stomach or gastroesophageal junction adenocarcinoma who have progressed after prior therapy.

  Recruiting Phase 2 Shanghai Henlius Biotech · Beijing · NCT07115485

• Utidelone plus fluoropyrimidine-and-platinum chemotherapy for first-line gastric or gastroesophageal junction adenocarcinoma

  This trial tests whether adding utidelone capsules to standard fluoropyrimidine-and-platinum chemotherapy helps people with untreated locally advanced or metastatic stomach or gastroesophageal junction adenocarcinoma.

  Recruiting at 6 sites Phase 2/3 Beijing Biostar Pharmaceuticals Co., Ltd. · Hialeah, Florida and 9 other locations · NCT06841679

• Evaluating LM-302 with Candonilimab and Capecitabine for Advanced Gastric Cancer

  This study is testing a new combination of treatments for people with advanced stomach cancer to see if it can help them fight the disease better.

  Recruiting Phase 2 Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT06587425

• Treatment of advanced gastric, pancreatic, and biliary tract cancers with Spevatamig

  This study is testing a new treatment called Spevatamig for people with advanced stomach, pancreatic, or bile duct cancers to see if it works better alone or with other cancer therapies.

  Recruiting at 10 sites Phase 1/2 Phanes Therapeutics · Duarte, California and 10 other locations · NCT05482893

Related topics

Quick answers

How many Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →